IL17A and Autoimmunity: These data indicate that, while constraint of IL-17 signaling by Regnase-1 is beneficial in preventing autoimmunity, this same inhibition limits the efficacy of IL-17 in mediating renal host defense; thus, care will be needed when considering targeting this pathway pharmacologically.